Patients and the public have a history of participation and advocacy in cancer research, generally for the benefit of future cancer patients rather than themselves. Participation is necessary if drugs and treatments are to be properly tested. Advocacy adds a unique perspective that enables the integration of two valuable and powerful viewpoints, the experiential disease and treatment knowledge, needs and priorities of the patient, and the professional disease and treatment knowledge and priorities of the researcher or clinician. This synergistic combination is a key enabler for focused and relevant diagnostic and treatment advances in cancer research. However, recruitment of the right numbers and profile of patients and the public into participation and advocacy remains a challenge. This book seeks to take the mystery out of participation and advocacy in cancer research trials by explaining the whole process, in lay terms, in the hope that more people will be encouraged to participate and become advocates.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Ray Gardner was born in 1947. He worked at Royal Dutch Shell for 40 years in London, The Hague, and Houston. He retired in 2005 and then studied for a science degree at The Open University.
In 2018, Ray was diagnosed with myasthenia gravis and prostate cancer. Following successful treatment, he joined the Patient/Carer Advisory Group and the Senior Adult Oncology Programme at the Royal Marsden as a patient advocate. He then became involved in advocacy at the Institute of Cancer Research. He has also participated in a cancer research trial.
Ray is married, with two daughters, a son-in-law and two grandchildren.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : WorldofBooks, Goring-By-Sea, WS, Royaume-Uni
Paperback. Etat : Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged. N° de réf. du vendeur GOR014847470
Quantité disponible : 2 disponible(s)
Vendeur : WorldofBooks, Goring-By-Sea, WS, Royaume-Uni
Paperback. Etat : Fine. N° de réf. du vendeur GOR014594938
Quantité disponible : 1 disponible(s)
Vendeur : WeBuyBooks, Rossendale, LANCS, Royaume-Uni
Etat : Very Good. Most items will be dispatched the same or the next working day. A copy that has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged. N° de réf. du vendeur rev8779908754
Quantité disponible : 1 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 49967740
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 49967740-n
Quantité disponible : Plus de 20 disponibles
Vendeur : Rarewaves.com USA, London, LONDO, Royaume-Uni
Paperback. Etat : New. N° de réf. du vendeur LU-9781035878642
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur GB-9781035878642
Quantité disponible : 2 disponible(s)
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. N° de réf. du vendeur I-9781035878642
Quantité disponible : Plus de 20 disponibles
Vendeur : Rarewaves USA, OSWEGO, IL, Etats-Unis
Paperback. Etat : New. N° de réf. du vendeur LU-9781035878642
Quantité disponible : 1 disponible(s)
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Paperback. Etat : new. Paperback. Patients and the public have a history of participation and advocacy in cancer research, generally for the benefit of future cancer patients rather than themselves. Participation is necessary if drugs and treatments are to be properly tested. Advocacy adds a unique perspective that enables the integration of two valuable and powerful viewpoints, the experiential disease and treatment knowledge, needs and priorities of the patient, and the professional disease and treatment knowledge and priorities of the researcher or clinician. This synergistic combination is a key enabler for focused and relevant diagnostic and treatment advances in cancer research. However, recruitment of the right numbers and profile of patients and the public into participation and advocacy remains a challenge. This book seeks to take the mystery out of participation and advocacy in cancer research trials by explaining the whole process, in lay terms, in the hope that more people will be encouraged to participate and become advocates. Patients and the public have a history of participation and advocacy in cancer research, generally for the benefit of future cancer patients rather than themselves. Participation is necessary if drugs and treatments are to be properly tested. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9781035878642
Quantité disponible : 1 disponible(s)